Skip to content

Clinical trials

Phase 2 Lymphoma, Non-Hodgkin trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 2 Country / region: Switzerland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20081
20181
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
International Extranodal Lymphoma Study Group (IELSG)2
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
German High-Grade Non-Hodgkin's Lymphoma Study Group1
Hoffmann-La Roche1
MEI Pharma, Inc.1
Merck Sharp & Dohme LLC1
Oncology Institute of Southern Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin9
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse4
Burkitt Lymphoma3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Large-Cell, Immunoblastic3
Breast Neoplasms2
Carcinoma, Ovarian Epithelial2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.